Iht Wealth Management, LLC Editas Medicine, Inc. Transaction History

Iht Wealth Management, LLC

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$6.36 - $11.47 $8,814 - $15,897	-1,386 Reduced 11.23%	10,953 $90,000
Q1 2023 May 15, 2023	SELL	$7.03 - $11.53 $1,673 - $2,744	-238 Reduced 1.89%	12,339 $89,000
Q4 2022 Feb 14, 2023	SELL	$8.32 - $13.21 $7,329 - $11,638	-881 Reduced 6.55%	12,577 $111,000
Q3 2022 Nov 22, 2022	BUY	$12.16 - $19.42 $163,649 - $261,354	13,458 New	13,458 $165,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $175,920 - $268,816	-6,626 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$39.27 - $72.94 $154,488 - $286,945	-3,934 Reduced 37.25%	6,626 $272,000
Q2 2021 Aug 16, 2021	BUY	$31.29 - $56.64 $45,620 - $82,581	1,458 Added 16.02%	10,560 $598,000
Q1 2021 May 18, 2021	BUY	$39.71 - $90.58 $35,421 - $80,797	892 Added 10.86%	9,102 $382,000
Q4 2020 Feb 17, 2021	BUY	$27.07 - $84.35 $222,244 - $692,513	8,210 New	8,210 $576,000
Q2 2018 Aug 13, 2018	SELL	$31.4 - $41.01 $6,405 - $8,366	-204 Closed	0 $0
Q1 2018 May 15, 2018	BUY	$29.84 - $44.08 $2,208 - $3,261	74 Added 56.92%	204 $6,000
Q4 2017 Feb 14, 2018	BUY	$21.89 - $31.34 $394 - $564	18 Added 16.07%	130 $4,000
Q3 2017 Nov 14, 2017	BUY	$15.81 - $24.01 $1,770 - $2,689	112	112 $3,000

240

56.5M

410K

394K

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $85.9M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.